Our study did not utilize sectioning or immunohistochemistry/staining techniques to look for accumulation of AD biomarkers (Aβ, p-tau), nor did we look at markers of glial/immune activation, neurodegeneration, necrosis, or autophagy. This evidence concerns the gene MAPT and Alzheimer disease.